Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value:
$790.03M
Total Bought:
$0
Total Sold:
$83.19M
Net Transaction:
-$83.19M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Kymera Therapeutics, Inc.(KYMR)4,659,8744,578,008-81,866$362.58M$381.30M48.26%+$18.72M
Dyne Therapeutics, Inc.(DYN)9,130,4659,130,4650$178.59M$165.54M20.95%-$13.06M
Sionna Therapeutics, Inc.(SION)2,995,6022,995,6020$123.24M$120.09M15.20%-$3.15M
Disc Medicine, Inc.(IRON)1,513,8751,513,8750$120.22M$96.80M12.25%-$23.42M
Q32 Bio Inc.(QTTB)2,092,1062,092,1060$6.95M$13.43M1.70%+$6.49M
Korro Bio, Inc.(KRRO)1,137,1491,137,1490$9.11M$12.87M1.63%+$3.76M
Day One Biopharmaceuticals, Inc.
COM
6,412,5600-6,412,560$59.77M$0—-$59.77M
Generation Bio, Co.827,9460-827,946$4.70M$0—-$4.70M
Page 1 of 1
Atlas Venture Life Science Advisors, LLC — 13F Holdings — Q1 2026 | TickerTrail